Advertisement
U.S. markets close in 3 hours 6 minutes
  • S&P 500

    5,251.47
    +2.98 (+0.06%)
     
  • Dow 30

    39,763.67
    +3.59 (+0.01%)
     
  • Nasdaq

    16,382.82
    -16.70 (-0.10%)
     
  • Russell 2000

    2,129.48
    +15.13 (+0.72%)
     
  • Crude Oil

    82.86
    +1.51 (+1.86%)
     
  • Gold

    2,245.40
    +32.70 (+1.48%)
     
  • Silver

    25.02
    +0.27 (+1.10%)
     
  • EUR/USD

    1.0804
    -0.0026 (-0.24%)
     
  • 10-Yr Bond

    4.1930
    -0.0030 (-0.07%)
     
  • GBP/USD

    1.2639
    +0.0001 (+0.01%)
     
  • USD/JPY

    151.3000
    +0.0540 (+0.04%)
     
  • Bitcoin USD

    70,791.34
    +1,827.64 (+2.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

SHAREHOLDER ALERT: PTON PCT FREQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / June 21, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Peloton Interactive, Inc. (NASDAQ:PTON)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/peloton-interactive-inc-loss-submission-form?prid=17041&wire=1
Lead Plaintiff Deadline: June 28, 2021
Class Period: September 11, 2020 - May 5, 2021

Allegations against PTON include that: (1) in addition to the tragic death of a child, Peloton's Tread+ had caused a serious safety threat to children and pets as there were multiple incidents of injury to both; (2) safety was not a priority to Peloton as defendants were aware of serious injuries and death resulting from the Tread+, yet did not recall or suggest a halt of the use of the Tread+; (3) as a result of the safety concerns, the U.S. Consumer Product Safety Commission ("CPSC") declared that the Tread+ posed a serious risk to public health and safety and urgently recommended that consumers with small children cease using the Tread+; (4) the CPSC also found a safety threat to Tread+ users if they lost their balance; and (5) as a result of the foregoing, defendants' statements about Peloton's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

PureCycle Technologies, Inc. (NASDAQ:PCT)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/purecycle-technologies-inc-loss-submission-form?prid=17041&wire=1
Lead Plaintiff Deadline: July 12, 2021
Class Period: November 16, 2020 - May 5, 2021

Allegations against PCT include that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle's financial projections are baseless; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Frequency Therapeutics, Inc. (NASDAQ:FREQ)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/frequency-therapeutics-inc-loss-submission-form?prid=17041&wire=1
Lead Plaintiff Deadline: August 2, 2021
Class Period: November 16, 2020 - March 22, 2021

Allegations against FREQ include that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/652484/SHAREHOLDER-ALERT-PTON-PCT-FREQ-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

Advertisement